Insiders · Profile

Samuel George A. III

General Counsel at Lineage Cell Therapeutics. Filing since 26 Nov 2024. CIK 0001878732

Company

Date

Role

Action

Shares

Amount

Of holding

LCTX Lineage Cell Therapeutics, Inc.

26 Nov 2024

General Counsel

Bought

15,000

$9.00K

209%

1 decision on file.